Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
00:00:03 10/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 104.71 USD | +2.52% |
|
+12.28% | +22.83% |
| 11-05 | UBS Adjusts Price Target on Edwards Lifesciences to $118 From $110, Maintains Buy Rating | MT |
| 11-05 | RBC Lifts Price Target on Edwards Lifesciences to $115 From $110, Keeps Outperform Rating | MT |
| Market Cap | 60.21B 53.74B 49.45B 44.88B 85.06B 5,643B 87.17B 592B 236B 3,021B 226B 221B 9,516B | P/E 2026 * |
44.6x | P/E 2027 * | 31.8x |
|---|---|---|---|---|---|
| Enterprise Value | 56.67B 50.59B 46.55B 42.25B 80.06B 5,312B 82.05B 557B 222B 2,844B 213B 208B 8,957B | EV / Sales 2026 * |
8.32x | EV / Sales 2027 * | 7.37x |
| Free-Float |
86.64% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Tradegate
| EWL | Real-time | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Xetra
| EWL | Delayed | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +2.52% | ||
| 1 week | +12.28% | ||
| Current month | +13.80% | ||
| 1 month | +22.88% | ||
| 3 months | +16.71% | ||
| 6 months | +30.95% | ||
| Current year | +22.83% |
| 1 week | 96.72 |  | 105.37 |
| 1 month | 84.55 | | 105.37 |
| Current year | 74.66 | | 105.37 |
| 1 year | 74.66 | | 105.37 |
| 3 years | 58.93 | | 105.37 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 29/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 10/02/2015 |
| Director/Board Member | 58 | 11/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/8/26 A | Exercice | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 9/14/26 A | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 9/13/26 A | Tax | Controller/Auditor | -253 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.52% | +12.28% | +25.57% | +61.96% | 58.73B | |
| +3.87% | +5.71% | +26.07% | +62.43% | 257B | |
| +2.12% | +3.14% | +11.99% | +20.25% | 162B | |
| +1.71% | +5.42% | -17.76% | +69.07% | 157B | |
| +2.97% | -0.68% | -55.99% | -14.41% | 61.96B | |
| -3.36% | -0.55% | -0.30% | -10.70% | 55.42B | |
| +3.10% | +4.76% | +22.78% | +67.23% | 49.27B | |
| +0.88% | -0.20% | +3.91% | +83.91% | 49.18B | |
| +4.17% | +6.04% | +28.25% | +88.36% | 44.96B | |
| +2.00% | +5.63% | +15.03% | +23.01% | 37.25B | |
| Average | +2.00% | +4.03% | +5.96% | +45.11% | 93B | |
| Weighted average by Cap. | +2.37% | +4.40% | +7.53% | +47.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.81B 6.08B 5.6B 5.08B 9.62B 639B 9.86B 66.93B 26.68B 342B 25.57B 25.02B 1,077B | 7.48B 6.67B 6.14B 5.57B 10.56B 701B 10.83B 73.47B 29.29B 375B 28.07B 27.47B 1,182B |
| Net income | 1.36B 1.22B 1.12B 1.02B 1.93B 128B 1.98B 13.41B 5.34B 68.48B 5.12B 5.01B 216B | 1.88B 1.68B 1.55B 1.4B 2.66B 177B 2.73B 18.51B 7.38B 94.54B 7.07B 6.92B 298B |
| Net Debt | -3.54B -3.16B -2.9B -2.64B -4.99B -331B -5.12B -34.74B -13.85B -177B -13.27B -12.99B -559B | -5.09B -4.55B -4.18B -3.8B -7.2B -478B -7.38B -50.06B -19.95B -256B -19.12B -18.71B -805B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/11/26 | $104.71 | +2.52% | 6,683,068 |
| 06/11/26 | $102.14 | +1.31% | 5,112,770 |
| 05/11/26 | $100.82 | +1.46% | 9,233,947 |
| 04/11/26 | $99.37 | +4.39% | 7,897,496 |
| 03/11/26 | $95.19 | +2.07% | 6,559,254 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
